- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Overweight in Czechia
Total 41 results
-
Spatz FGIA, IncCompletedOverweight and ObesityCzechia
-
ENDOPLYJust 4 Device s.r.o.Not yet recruiting
-
Charles University, Czech RepublicMinistry of Health, Czech Republic; EXCELES LX22NPO5104, CarDiaRecruiting
-
Institute for Clinical and Experimental MedicineNot yet recruiting
-
Endobar Solutions LLCNa Homolce Hospital; OB KLINIKA a.s. Pod Krejcárkem 975 Praha 3 - Žižkov Tel... and other collaboratorsCompletedObesity, MorbidCzechia
-
Nitinotes Surgical Ltd.Active, not recruiting
-
University Hospital OstravaUniversity of Ostrava; Vítkovice Hospital Ostrava, Czech RepublicCompleted
-
GT Metabolic Solutions, Inc.Recruiting
-
Gelesis, Inc.CompletedObesity | OverweightItaly, Denmark, Czechia
-
Vitadio s.r.o.University Hospital OlomoucCompletedObesity | Diabetes Mellitus, Type 2 | Insulin Resistance | Prediabetic StateCzechia
-
Faculty Hospital Kralovske VinohradyRecruitingBody Weight Changes | Adolescent Obesity | Life Style, Healthy | Cardiometabolic SyndromeCzechia
-
University of OstravaInstitute for Clinical and Experimental Medicine; Vitkovice HospitalActive, not recruiting
-
University Hospital OstravaUniversity of OstravaCompleted
-
St. Anne's University Hospital Brno, Czech RepublicCompletedSleep Disorder | Body Fat DistributionCzechia
-
Gelesis, Inc.CompletedOverweight and ObesityUnited States, Czechia, Denmark, Italy, Spain
-
SanionaCompletedConfirmed Genetic Diagnosis of Prader-Willi SyndromeCzechia, Hungary
-
Allurion TechnologiesUnknownObesity | OverweightCzech Republic, Greece
-
Novo Nordisk A/SCompleted
-
Ethicon Endo-SurgeryTerminatedMorbid ObesityUnited States, Czech Republic
-
Nemocnice Břeclav, p.o.UnknownDiabetes Mellitus, Type 2 | Obesity, SevereCzech Republic
-
Ethicon Endo-SurgeryCompletedMorbid ObesityCzech Republic, Australia
-
Novartis PharmaceuticalsCompletedObesity | OverweightAustria, United Kingdom, United States, Slovakia, Hungary, Czechia, Canada
-
Gelesis, Inc.CompletedStudy of Gelesis100 on Body Weight in Overweight and Obese Subjects With and Without Type 2 DiabetesObesity | OverweightUnited States, Canada, Czechia, Denmark, Italy, Spain
-
Eli Lilly and CompanyRecruitingObesity | OverweightUnited States, Canada, Italy, Czechia, Israel, Mexico, Poland
-
Gelesis, Inc.UnknownObesity | Diabetes | Overweight | PreDiabetesUnited States, United Kingdom, Poland, Hungary, Italy, Canada, Czechia, Denmark
-
Novo Nordisk A/SActive, not recruitingObesityUnited States, Czechia, Germany, Canada, Hungary, Portugal, Norway, South Africa, Poland, Greece, Bulgaria, Slovakia
-
Eli Lilly and CompanyNot yet recruitingOverweight and ObesityUnited States, Canada, Australia, Germany, Mexico, Argentina, Brazil, Hungary, Austria, India, Poland, Slovakia, Spain, Netherlands, Turkey, Czechia, United Kingdom, Denmark, Puerto Rico, France, Israel
-
Gedeon Richter Plc.RecruitingPrader-Willi SyndromeUnited States, Spain, Czechia, Italy, France
-
Novo Nordisk A/SCompletedObesityUnited States, Israel, United Kingdom, Denmark, Germany, Netherlands, Canada, Argentina, Czechia, Hungary, Poland, Spain, Australia
-
Eli Lilly and CompanyActive, not recruitingObesity | OverweightSpain, United States, Australia, Italy, Hungary, India, Israel, Canada, China, Taiwan, United Kingdom, Belgium, France, Germany, Mexico, Romania, Poland, Argentina, Brazil, Puerto Rico, Austria, Turkey, Japan, Netherlands, Korea, Republic... and more
-
PfizerTerminatedObesityUnited States, Australia, Canada, Brazil, Slovakia, Czech Republic, Argentina, Germany, Mexico, United Kingdom, Sweden
-
PfizerTerminatedObesity | Diabetes MellitusUnited States, Hungary, Canada, Japan, Poland, Puerto Rico, Bulgaria, Czechia
-
AstraZenecaMedImmune LLCCompletedDiabetes Mellitus, Type 2Germany, United States, Canada, Russian Federation, Slovakia, Czechia, Bulgaria, Mexico
-
Novo Nordisk A/SCompletedObesity | OverweightUnited States, France, Spain, Taiwan, United Kingdom, Germany, India, Brazil, Canada, Japan, Malaysia, Russian Federation, Australia, Norway, Mexico, Netherlands, Portugal, Hungary, Italy, Austria, Greece, South Africa, Turkey, Finland, Puerto Rico and more
-
Boehringer IngelheimRecruitingObesityUnited States, Korea, Republic of, Belgium, Australia, United Kingdom, Spain, Germany, Taiwan, Netherlands, Brazil, Hungary, Denmark, Canada, Poland, Austria, China, Finland, Greece, Italy, Hong Kong, Czechia, Portugal, Saudi Arabia, ... and more
-
AmgenActive, not recruitingObesity | Overweight | Type 2 Diabetes MellitusUnited States, Czechia, Taiwan, Canada, Japan, Korea, Republic of, Germany, Hungary, Australia, Hong Kong, Spain, Poland
-
Boehringer IngelheimRecruitingObesity | Diabetes Mellitus, Type 2United States, Belgium, Korea, Republic of, Greece, Australia, Spain, Denmark, China, New Zealand, Poland, Canada, Finland, Germany, Hungary, United Kingdom, Japan, Netherlands, Sweden, Czechia
-
Eli Lilly and CompanyActive, not recruitingObesity | Overweight | Type 2 DiabetesUnited States, China, Australia, India, Germany, Greece, Argentina, Korea, Republic of, Brazil, Czechia, Puerto Rico
-
SanofiCompletedObesity | Diabetes Mellitus, Non-Insulin-Dependent | Obesity in DiabetesUnited States, France, Canada, Poland, Germany, Netherlands, Belgium, Czech Republic, Argentina, Finland, United Kingdom
-
Eli Lilly and CompanyCompletedObesity | Sleep ApneaUnited States, China, Taiwan, Germany, Mexico, Brazil, Japan, Czechia, Australia, Puerto Rico
-
Eli Lilly and CompanyRecruitingCardiovascular Diseases | Obesity | Overweight | Type 2 Diabetes | Chronic Kidney Disease | Overweight or ObesityUnited States, Italy, Spain, Korea, Republic of, India, Turkey, Austria, Puerto Rico, Mexico, Romania, Brazil, Germany, Argentina, Czechia, Greece, Slovakia